NIKOLE DAHLKE: Open Payments
NPI 1356936777 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 84 payments from 17 companies in 2025. Trend: 2023 $1,160 · 2024 $3,450 · 2025 $1,602
Food & beverage: $1,602
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $235 |
| Novartis Pharmaceuticals Corporation | 14 | $222 |
| Amgen Inc. | 10 | $195 |
| AstraZeneca Pharmaceuticals LP | 11 | $187 |
| ANI Pharmaceuticals, Inc. | 6 | $109 |
| Mallinckrodt Hospital Products Inc. | 5 | $103 |
| Travere Therapeutics, Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Fresenius USA Marketing, Inc. | 4 | $80 |
| Corcept Therapeutics | 2 | $58 |
Products named: Kerendia, KRYSTEXXA, Fabhalta, PURIFIED CORTROPHIN GEL, VELPHORO, ACTHAR, JYNARQUE, Korlym.
Industry payments across GA — which companies pay providers there.
